Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Interview: EU Big Data Task Force Is ‘Not Just Another Discussion Forum’, Says Chair Thomas Senderovitz

Executive Summary

A month after EU regulators created a task force to work out how to use big data to support drug evaluation, Thomas Senderovitz, the head of the Danish Medicines Agency who chairs the new group, tells the Pink Sheet’s Vibha Sharma what to expect from the initiative.

You may also be interested in...

“We Regulators Need To Get Our Heads Round Big Data”: EU Task Force Chair

The EU big data task force seems to be on track to deliver in 2018 an EU-wide strategy on how big data can be used to support the development and evaluation of medicines. Some aspects of big data, such as social media and mobile health, have proved to be more challenging than others, says task force co-chair Thomas Senderovitz.

Denmark Leads New EU Task Force Exploring Use Of Big Data In Medicines Assessment

EU drug regulators have created a new task force to establish a roadmap and recommendations on how to use big data in the assessment of medicines.

EMA And National Agency Heads Join Forces On Medicines Availability and Big Data

The European Medicines Agency and the EU Heads of Medicines Agencies network are working together on a broad range of subjects, from big data to the availability of medicines… and of course, Brexit.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts